S&P 500 Freddie Mac Fannie Mae (11 lettori)

Sheppy

Forumer storico
NVAX FDA dovrebbe dargli la licenza per il vaccino io aspetto quello ... non intraday trading

NVAX a clinical-stage biopharmaceutical company, focuses on developing vaccines using its virus-like particle platform technology for infectious diseases. It develops vaccines against the H5N1 and other subtypes of avian influenza with pandemic potential, human seasonal influenza, and Respiratory Syncytial Virus, as well as Varicella Zoster that causes shingles.

 

Users who are viewing this thread

Alto